Is ALMR or ATRC more profitable?

ATRC runs the higher net margin — ALMR at -40.18% versus ATRC at 1.85%.

Alamar Biosciences, Inc. (ALMR) vs AtriCure, Inc. (ATRC)

A side-by-side comparison of Alamar Biosciences, Inc. and AtriCure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALMR

Alamar Biosciences, Inc.

$2.39B

$34.47HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

ATRC

AtriCure, Inc.

$2.79B

$54.88HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — ALMR vs ATRC

growth of $100 · dividends reinvested · last 1y

ALMR +73.3% (+73.3%/yr)ATRC +96.7% (+96.7%/yr)ATRC compounded faster over this window

ALMR ATRC

ALMR vs ATRC: by the numbers

•ATRC is the larger company ($2.79B vs $2.39B market cap).
•ATRC is profitable (1.85% net margin) while ALMR runs a net loss (-40.18%).

Metrics side by side

Valuation

Metric	ALMR	ATRC
P/E ratio	N/A	258.60
P/S ratio	N/A	4.90
P/B ratio	7.64	5.40
EV / EBITDA	N/A	77.55
FCF yield	N/A	1.84%

Profitability

Metric	ALMR	ATRC
Gross margin	56.20%	76.16%
Operating margin	-42.22%	2.44%
Net margin	-40.18%	1.85%
ROE	N/A	2.04%
ROIC	-26.95%	2.04%

Growth (annualized)

Metric	ALMR	ATRC
Revenue CAGR (5Y)	N/A	18.57%
Total return CAGR (5Y)	N/A	-4.06%

Frequently asked

Is ALMR or ATRC more profitable?: ATRC runs the higher net margin — ALMR at -40.18% versus ATRC at 1.85%.

Go deeper

Full ALMR analysis Full ATRC analysis Interactive comparison tool

Dig into the metrics

AtriCure P/E ratio Alamar Biosciences ROE AtriCure ROE Alamar Biosciences operating margin AtriCure operating margin Alamar Biosciences revenue growth AtriCure revenue growth Alamar Biosciences free cash flow AtriCure free cash flow

Alamar Biosciences & AtriCure appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.